3PBIOVIAN
Timothy S. Gomez is an accomplished professional in the field of business development and immunology, currently serving as Associate Director of Business Development at 3PBIOVIAN since February 2024. Previously, Timothy held various roles at 3P Biopharmaceuticals, including Associate Director of Business Development, Head of Business Development, and Business Development Manager, from September 2019 to February 2024. Additional experience includes a position as Business Development Manager at Mundipharma and Cinfa Biotech. Timothy's early career includes roles as Medical Writer at IRMEDICA S.L. and Koonec Medical Writing and Translation, as well as an academic background at the Mayo Clinic, where contributions spanned from Assistant Professor in the Department of Immunology to Postdoctoral Research Scientist in Oncology Research. Timothy holds a PhD in Immunology from Mayo Clinic Alix School of Medicine, a B.S. in Microbiology from the University of Wisconsin-La Crosse, and a Master's degree in Executive Business Innovation from EOI Business School.
This person is not in any teams
3PBIOVIAN
3PBIOVIAN service offering includes microbial and mammalian protein expression platforms, viral vector production for adenoviruses and adeno-associated viruses, cell therapy, and plasmid DNA production, with the provision for fill and finish services for recombinant proteins and viral vectors. Leveraging a combined track record of 40 years in process development and analytical methods development, complemented by the experience in process scale-up, GMP manufacturing, and commercial supply, 3PBIOVIAN is equipped to offer comprehensive manufacturing services at all stages, encompassing Drug Substance and Drug Product. Manufacturing sites in Pamplona-Noáin, Spain, and Turku, Finland seamlessly support the diverse needs of clients, covering pre-clinical and clinical supply to full-scale commercial manufacturing.